Showing 1 - 20 results of 57 for search '"Drug-eluting stent"', query time: 0.07s Refine Results
  1. 1

    Drug deposition in coronary arteries with overlapping drug-eluting stents by Olgac, Ufuk, Poulikakos, Dimos, Kurtcuoglu, Vartan, Rikhtegar Nezami, Farhad, Edelman, Elazer R

    Published 2017
    “…Drug-eluting stents are accepted as mainstream endovascular therapy, yet concerns for their safety may be under-appreciated. …”
    Get full text
    Get full text
    Get full text
    Article
  2. 2

    Numerical modeling of local pharmacokinetics associated with drug-eluting stent by Jahid Ferdous

    Published 2009
    “…To restore distal blood supply and overcome restenosis presented by bare-metal stents, drug-eluting stent (DES) implantation is widely used. However, the long-term efficacy of this mode of treatment is not well-established. …”
    Get full text
    Thesis
  3. 3
  4. 4

    Modeling and Analysis of Drug-Eluting Stents With Biodegradable PLGA Coating: Consequences on Intravascular Drug Delivery by Zhu, Xiaoxiang, Braatz, Richard D

    Published 2017
    “…Increasing interests have been raised toward the potential applications of biodegradable poly(lactic-co-glycolic acid) (PLGA) coatings for drug-eluting stents in order to improve the drug delivery and reduce adverse outcomes in stented arteries in patients. …”
    Get full text
    Get full text
    Get full text
    Article
  5. 5

    Fracture in drug‐eluting stents increases focal intimal hyperplasia in the atherosclerosed rabbit iliac artery by Conway, Claire, Edelman, Elazer R

    Published 2020
    “…Objectives: Drug-eluting stent (DES) strut fracture (SF) is associated with higher incidence of In-stent restenosis (ISR)—return of blockage in a diseased artery post stenting—than seen with bare metal stents (BMS). …”
    Get full text
    Article
  6. 6

    The delivery of nitric oxide through liposomes as next generation drug eluting stents and vascular interventions by Tan, Wei Jie

    Published 2022
    “…Such means of fabrication would hopefully encourage others to pursue the use of NO for future drug eluting stents.…”
    Get full text
    Thesis-Doctor of Philosophy
  7. 7

    A bilayer swellable drug-eluting stent for the treatment of fibrosis-induced ureteral stricture recurrence by Lim, Wei Shan

    Published 2018
    “…It is hypothesized that a bilayer swellable drug-eluting stent (BSDES) that can co-apt with the urothelium for the localized and sustained delivery of drugs into the diseased section can reduce or eliminate stricture recurrence. …”
    Get full text
    Thesis
  8. 8
  9. 9

    Characterization and evaluation of a bilayer swellable drug-eluting stent for the treatment of fibrosis-induced ureteral stricture by Er, Pei Shan

    Published 2017
    “…The bilayer swellable drug eluting stent is fabricated by first spraycoating an antiproliferative drug, mitomycin C (MMC) encapsulated in a hydrophobic polymer, poly-L-lactide-co-caprolactone (PLC) onto the stent, followed by surface plasma treatment before coating a hydrogel, polyethylene glycol diacrylate (PEGDA) onto the polymer, via photo-crosslinking. …”
    Get full text
    Final Year Project (FYP)
  10. 10

    Comparison of overexpansion capabilities and thrombogenicity at the side branch ostia after implantation of four different drug eluting stents by Gasior, Pawel, Lu, Shengjie, Ng, Jaryl Chen Koon, Toong, Daniel Wee Yee, Wong, Philip En Hou, Foin, Nicolas, Kedhi, Elvin, Wojakowski, Wojciech, Ang, Hui Ying

    Published 2021
    “…This study aimed to evaluate the overexpansion capabilities and thrombogenicity at the SB ostia after implantation of four latest generation drug-eluting stents (DES) in an in-vitro bifurcation model. …”
    Get full text
    Journal Article
  11. 11

    Modelling intravascular delivery from drug-eluting stents with biodurable coating: investigation of anisotropic vascular drug diffusivity and arterial drug distribution by Zhu, Xiaoxiang, Pack, Daniel W., Braatz, Richard D.

    Published 2016
    “…In-stent restenosis occurs in coronary arteries after implantation of drug-eluting stents with non-uniform restenosis thickness distribution in the artery cross section. …”
    Get full text
    Get full text
    Get full text
    Article
  12. 12
  13. 13
  14. 14

    Impact of flow pulsatility on arterial drug distribution in stent-based therapy by O’Brien, Caroline C., Kolachalama, Vijaya Bhasker, Barber, Tracie J., Simmons, Anne, Edelman, Elazer R.

    Published 2014
    “…Drug-eluting stents reside in a dynamic fluid environment where the extent to which drugs are distributed within the arterial wall is critically modulated by the blood flowing through the arterial lumen. …”
    Get full text
    Get full text
    Get full text
    Article
  15. 15
  16. 16

    Pathology of Endovascular Stents by Keating, John H., Nakamura, Kenta, Edelman, Elazer R

    Published 2018
    “…Keywords: Coronary artery disease; Pathology; Bare metal stent; Drug-eluting stent; In-stent restenosis; In-stent thrombosis; Atherosclerosis; Neoatherosclerosis…”
    Get full text
    Get full text
    Get full text
    Article
  17. 17

    In vitro peptide release from e-polycaprolactone and blends of e-polycaprolactone by Adhi Kurnianto

    Published 2010
    “…Recent invention of drug-eluting stent (DES) has been successful to prevent ISR but signify a long term thrombosis effect. …”
    Get full text
    Final Year Project (FYP)
  18. 18

    Stent elution rate determines drug deposition and receptor-mediated effects by Tzafriri, Abraham R., Groothuis, Adam, Price, G. Sylvester, Edelman, Elazer R.

    Published 2016
    “…Drug eluting stent designs abound and yet the dependence of efficacy on drug dose and elution duration remains unclear. …”
    Get full text
    Get full text
    Article
  19. 19

    Evaluation of tissue adhesives for drug eluting balloon using the rotating cylinder by Lim, Cynthia Yun Yun.

    Published 2012
    “…A stent is also inserted to keep the diseased artery remain open. However, Drug Eluting Stent (DES) is still not a good solution to atherosclerosis as it will cause the onset of late stent restenosis. …”
    Get full text
    Final Year Project (FYP)
  20. 20

    Evaluation of pressure sensitive adhesives for drug eluting balloon by Wang, Dione Qian Ying

    Published 2011
    “…A stent helps to keep the artery remain open. Although drug eluting stents and drug eluting balloons have been designed, drug eluting stent is not a good solution as restenosis will cause the diseased coronary artery to close after a few years. …”
    Get full text
    Final Year Project (FYP)